View
About the views

Guided View. New to dividends? Yields, ex-dividend dates, payout ratios, DRIP: we explain every term as you browse, in plain English. Same data, with the help built in.

Expert View. You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Theme
Dividendly Independent dividend research

← Back to declarations

GILD Gilead Sciences, Inc. — dividend yield, history & ex-dividend dates

NASDAQ Global Select· Quarterly dividend· Common Stock · Healthcare / Drug Manufacturers - General

$165.61 ▲ $6.41(4.03%) as of Oct 30, 2026 06:20 UTC
Sponsored Advanced charts & data →

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.

Dividend Snapshot

StatusGrowing
Last Dividend$0.8200Paid Sep 29, 2026
Forward Annual$3.28From the $0.8200 dividend declared Jul 28, 2026
FrequencyQuarterly
Last Ex-DateSep 15, 2026The most recent ex-dividend date that has already passed.
1-Yr Growth2.6%Annual totals, 2024–2025

Research Scores

Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.

Dividend Safety Score

93/100

Very strong indicators

Complete data

Dividend Growth Score

77/100

Strong growth record

Complete data

Dividend Value Score

32/100

Above own historical valuation

Complete data

DividendRank

70/100

Upper middle of the scale

Complete data

How the Dividend Safety Score is built for GILD
InputValuePointsWeight
Earnings payout ratioEarnings payout ratio 44% (TTM to Mar 31, 2026) 96 20%
FCF payout ratioFCF payout ratio 39% (TTM to Mar 31, 2026) 100 25%
Net debt / EBITDANet debt / EBITDA 1.0x (TTM to Mar 31, 2026) 99 15%
Interest coverageInterest coverage 11.2x (TTM to Mar 31, 2026) 92 10%
Dividend record11 years of uninterrupted regular payments 71 20%
Earnings stabilityNet income positive in 5 of the last 5 fiscal years (FY2021–FY2025) 100 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Growth Score is built for GILD
InputValuePointsWeight
5-year dividend growth5-year dividend CAGR 3.0% (2020–2025) 55 25%
Consecutive annual increases9 consecutive annual increases (through 2025) 76 20%
Payout headroomHeadroom from the earnings payout ratio 44% (TTM to Mar 31, 2026) 94 20%
Earnings per share growth (3 years)EPS CAGR 23.0% (FY2022–FY2025) 100 15%
Revenue growth (3 years)Revenue CAGR 2.6% (FY2022–FY2025) 62 10%
10-year dividend growthN/A (not used) N/A 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Value Score is built for GILD
InputValuePointsWeight
Yield vs own historyCurrent yield at the 0th percentile of its 120 month-end yields 0 40%
P/E vs own 5-year medianP/E 21.2 is 1.17x its 5-year median of 18.1 28 25%
FCF yieldFCF yield 5.0% (TTM to Mar 31, 2026) 67 20%
P/E vs peersP/E 21.2 vs peer median 26.8 (0.79x; 45 corporation / Healthcare securities) 76 15%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

Key Metrics

Current Yield

1.98%

At the Oct 30, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$3.2800

Declared Jul 28, 2026

The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.

Frequency

Q Quarterly

How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

RSI (14)

70

As of Oct 30, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$117.88 – $157.37

Closes through Oct 23, 2026

The lowest and highest price over the past year, showing where today's price sits in its recent range.

Payout Ratio (TTM)

n/a

12 months to Jun 30, 2026 (Q2 FY2026)

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

11

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (TTM)

16.40

Price as of Oct 25, 2026; latest reported book value

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is a set of four checks on a dividend's record and the company's data, the same test used across the screener and our ranked lists. Solid: a Dividend Safety Score of 70+ and a yield of 2%+. Accelerating: at least three consecutive completed calendar years of higher total regular dividends. Flawless: since 1990, no calendar year whose total regular dividend fell more than 20% below the year before, and no suspension. Enduring: at least 20 years between the first and latest dividend in our records. All four met earns the S.A.F.E. flag.
S Solid
Below the Solid check (Dividend Safety Score 70+ and yield 2%+): Dividend Safety Score 93/100, yield 1.98%.
A Accelerating
9 consecutive years of dividend increases.
F Flawless
No calendar year's regular dividend total fell more than 20% below the year before, and no suspension of the regular dividend is on record.
E Enduring
11 year(s) of payments on record, under the 20 this check looks for.

Quote & Key Data

ExchangeNASDAQ Global SelectThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume6,070,932Oct 23, 2026 sessionHow many shares changed hands in the trading session dated beside this figure, a rough read on trading activity. Daily bars are refreshed on a slower cycle than the quoted price, so this session can be older than the price above.
Open$156.47Oct 23, 2026 sessionThe price at the start of the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Day Range$155.76 – $157.65Oct 23, 2026 sessionThe lowest and highest price during the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Prev Close$157.19Close of Oct 22, 2026The closing price from the session before the one dated beside these figures.
Market Cap$205.35BAs of Oct 30, 2026The company's total market value (share price times shares outstanding) on the date shown.
Shares Out1.24BImplied by market cap, Oct 30, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (TTM)$-2.6112 months to Jun 30, 2026 (Q2 FY2026)Earnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (TTM)-60.0Price as of Oct 25, 2026; earnings to Jun 30, 2026Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Last Ex-DateSep 15, 2026Paid Sep 29, 2026The most recent ex-dividend date that has already passed.
Next Ex-DateN/ANone declared yetThe ex-dividend date of the next payment the company has declared, or that is scheduled when no declaration is on file. Future dates our data provider only projects are not shown.

Dividend Growth

3-Yr Growth (CAGR)2.7%Annual totals, 2022–2025The dividend's average annual growth rate over the period, compounded.
5-Yr Growth (CAGR)3.0%Annual totals, 2020–2025The dividend's average annual growth rate over the period, compounded.
Consecutive Increases9 yrsAnnual totals through 2025The number of consecutive years the dividend has increased.

Why the Yield Moved (90 Days)

GILD's dividend yield fell from 2.50% to 1.98% over the past ~90 days (-0.52 pp). Of that move, +0.00 pp came from changes in the dividend rate and -0.52 pp from the share price ($131.15 on Aug 03, 2026 → $165.61 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.

Yield vs Its Own History

Current1.98%
1-Yr Average2.41%
Low / High2.08% – 2.86%
Percentile0%

Across 272 daily observations over the past 13 months (through Oct 23, 2026), GILD's current yield is higher than approximately 0% of them. Our stored price history for GILD covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.8200 Q Regular Jul 28, 2026 Sep 15, 2026 Sep 15, 2026 Sep 29, 2026
$0.8200 Q Regular Apr 29, 2026 Jun 15, 2026 Jun 15, 2026 Jun 29, 2026
$0.8200 Q Regular Feb 04, 2026 Mar 13, 2026 Mar 13, 2026 Mar 30, 2026
$0.7900 Q Regular Oct 28, 2025 Dec 15, 2025 Dec 15, 2025 Dec 30, 2025
$0.7900 Q Regular Jul 29, 2025 Sep 15, 2025 Sep 15, 2025 Sep 29, 2025
$0.7900 Q Regular Apr 22, 2025 Jun 13, 2025 Jun 13, 2025 Jun 27, 2025
$0.7900 Q Regular Feb 11, 2025 Mar 14, 2025 Mar 14, 2025 Mar 28, 2025
$0.7700 Q Regular Nov 06, 2024 Dec 13, 2024 Dec 13, 2024 Dec 30, 2024
$0.7700 Q Regular Aug 08, 2024 Sep 13, 2024 Sep 13, 2024 Sep 27, 2024
$0.7700 Q Regular Apr 25, 2024 Jun 14, 2024 Jun 14, 2024 Jun 27, 2024
$0.7700 Q Regular Feb 01, 2024 Mar 14, 2024 Mar 15, 2024 Mar 28, 2024
$0.7500 Q Regular Nov 07, 2023 Dec 14, 2023 Dec 15, 2023 Dec 28, 2023
$0.7500 Q Regular Aug 03, 2023 Sep 14, 2023 Sep 15, 2023 Sep 28, 2023
$0.7500 Q Regular Apr 27, 2023 Jun 14, 2023 Jun 15, 2023 Jun 29, 2023
$0.7500 Q Regular Feb 02, 2023 Mar 14, 2023 Mar 15, 2023 Mar 30, 2023
$0.7300 Q Regular Oct 27, 2022 Dec 14, 2022 Dec 15, 2022 Dec 29, 2022
$0.7300 Q Regular Aug 02, 2022 Sep 14, 2022 Sep 15, 2022 Sep 29, 2022
$0.7300 Q Regular Apr 28, 2022 Jun 14, 2022 Jun 15, 2022 Jun 29, 2022
$0.7300 Q Regular Feb 01, 2022 Mar 14, 2022 Mar 15, 2022 Mar 30, 2022
$0.7100 Q Regular Oct 28, 2021 Dec 14, 2021 Dec 15, 2021 Dec 30, 2021
$0.7100 Q Regular Jul 29, 2021 Sep 14, 2021 Sep 15, 2021 Sep 29, 2021
$0.7100 Q Regular Apr 27, 2021 Jun 14, 2021 Jun 15, 2021 Jun 29, 2021
$0.7100 Q Regular Feb 04, 2021 Mar 12, 2021 Mar 15, 2021 Mar 30, 2021
$0.6800 Q Regular Oct 28, 2020 Dec 14, 2020 Dec 15, 2020 Dec 30, 2020
$0.6800 Q Regular Jul 30, 2020 Sep 14, 2020 Sep 15, 2020 Sep 29, 2020
$0.6800 Q Regular Apr 29, 2020 Jun 11, 2020 Jun 12, 2020 Jun 29, 2020
$0.6800 Q Regular Feb 03, 2020 Mar 12, 2020 Mar 13, 2020 Mar 30, 2020
$0.6300 Q Regular Oct 23, 2019 Dec 12, 2019 Dec 13, 2019 Dec 30, 2019
$0.6300 Q Regular Jul 29, 2019 Sep 12, 2019 Sep 13, 2019 Sep 27, 2019
$0.6300 Q Regular May 01, 2019 Jun 13, 2019 Jun 14, 2019 Jun 27, 2019
$0.6300 Q Regular Feb 01, 2019 Mar 14, 2019 Mar 15, 2019 Mar 28, 2019
$0.5700 Q Regular Oct 24, 2018 Dec 13, 2018 Dec 14, 2018 Dec 28, 2018
$0.5700 Q Regular Jul 24, 2018 Sep 13, 2018 Sep 14, 2018 Sep 27, 2018
$0.5700 Q Regular Apr 30, 2018 Jun 14, 2018 Jun 15, 2018 Jun 28, 2018
$0.5700 Q Regular Feb 05, 2018 Mar 15, 2018 Mar 16, 2018 Mar 29, 2018
$0.5200 Q Regular Oct 25, 2017 Dec 14, 2017 Dec 15, 2017 Dec 28, 2017
$0.5200 Q Regular Jul 27, 2017 Sep 14, 2017 Sep 15, 2017 Sep 28, 2017
$0.5200 Q Regular May 04, 2017 Jun 14, 2017 Jun 16, 2017 Jun 29, 2017
$0.5200 Q Regular Feb 08, 2017 Mar 14, 2017 Mar 16, 2017 Mar 30, 2017
$0.4700 Q Regular Nov 02, 2016 Dec 13, 2016 Dec 15, 2016 Dec 29, 2016
$0.4700 Q Regular Jul 26, 2016 Sep 14, 2016 Sep 16, 2016 Sep 29, 2016
$0.4700 Q Regular Apr 29, 2016 Jun 14, 2016 Jun 16, 2016 Jun 29, 2016
$0.4300 Q Regular Feb 02, 2016 Mar 14, 2016 Mar 16, 2016 Mar 30, 2016
$0.4300 Q Regular Oct 27, 2015 Dec 14, 2015 Dec 16, 2015 Dec 30, 2015
$0.4300 Q Regular Jul 29, 2015 Sep 14, 2015 Sep 16, 2015 Sep 29, 2015
$0.4300 Q Regular May 01, 2015 Jun 12, 2015 Jun 16, 2015 Jun 29, 2015

Peer Comparison

Selected Drug Manufacturers - General dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
ZTS Zoetis Inc. 2.69% 20.1% 11 yrs 94
BMY Bristol-Myers Squibb Company 4.10% 6.6% 18 yrs 86
ALPMY Astellas Pharma Inc. 3.10% 5.6% 11 yrs 80
ALPMF Astellas Pharma Inc. 2.87% 5.9% 3 yrs 80

Related Guides & Lists

GILD dividend — frequently asked questions

Does Gilead Sciences, Inc. pay a dividend?

Yes. Gilead Sciences, Inc. (GILD) currently pays a dividend. The annualized dividend is about $3.28 per share, a yield of approximately 1.98%.

What is Gilead Sciences, Inc.'s dividend yield?

Gilead Sciences, Inc.'s dividend yield is approximately 1.98%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does Gilead Sciences, Inc. pay dividends?

Gilead Sciences, Inc. pays dividends quarterly — 4 times per year.

How long has Gilead Sciences, Inc. paid dividends?

Gilead Sciences, Inc. has 11 years of dividend payments on record, and has increased its dividend for 9 consecutive years.

Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.